SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2188718

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2188718

Oral Analgesics Market Size, Share & Trends Analysis Report By Drug Class (Non-opioid Analgesics, Combination Analgesics), By Prescription Status, By Formulation, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Oral Analgesics Market Summary

The global oral analgesics market size was valued at USD 22.5 billion in 2025 and is projected to grow from USD 23.3 billion in 2026 to USD 31.0 billion in 2033, at a CAGR of 4.2% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 41.2% in 2025. The market is mature, supported by continued demand for medicines used to manage acute and chronic pain, including headache, musculoskeletal pain, dental pain, arthritis, menstrual pain, and postoperative pain.

Non-opioid medicines, particularly acetaminophen/paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), account for a major part of routine oral pain management because of their broad availability through prescription and over-the-counter channels. Recent U.S. data also show frequent use of acetaminophen, ibuprofen, and aspirin among adults, supporting continued demand for established oral pain medicines.

At the same time, opioid analgesics remain important for moderate to severe pain but face tighter safety controls due to risks related to misuse, dependence, and overdose. Regulatory focus is therefore shifting toward non-opioid pain medicines, while product development continues to focus on combination formulations, dosing convenience, safety, and longer pain relief.

Global Oral Analgesics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oral analgesics market report based on drug class, prescription status, formulation, distribution channel, and region:

  • Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)
  • Non-opioid Analgesics
  • Opioid Analgesics
  • Combination Analgesics
  • Prescription Status Outlook (Revenue, USD Billion, 2021 - 2033)
  • OTC
  • Prescription
  • Formulation Outlook (Revenue, USD Billion, 2021 - 2033)
  • Tablets / Caplets
  • Capsules
  • Oral Liquids
  • Others
  • Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Product Code: GVR-4-68041-065-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Prescription Status
    • 1.2.3. Formulation
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Oral Analgesics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Oral Analgesics Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2025 & 2033
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
  • 4.4. Non-opioid Analgesics
    • 4.4.1. Non-opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • 4.5. Opioid Analgesics
    • 4.5.1. Opioid Analgesics Market, 2021 - 2033 (USD Billion)
  • 4.6. Combination Analgesics
    • 4.6.1. Combination Analgesics Market, 2021 - 2033 (USD Billion)

Chapter 5. Oral Analgesics Market: Prescription Status Business Analysis

  • 5.1. Prescription Status Market Share, 2025 & 2033
  • 5.2. Prescription Status Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Prescription Status, 2021 to 2033 (USD Billion)
  • 5.4. OTC
    • 5.4.1. OTC Market, 2021 - 2033 (USD Billion)
  • 5.5. Prescription
    • 5.5.1. Prescription Market, 2021 - 2033 (USD Billion)

Chapter 6. Oral Analgesics Market: Formulation Business Analysis

  • 6.1. Formulation Market Share, 2025 & 2033
  • 6.2. Formulation Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Formulation, 2021 to 2033 (USD Billion)
  • 6.4. Tablets / Caplets
    • 6.4.1. Tablets / Caplets Market, 2021 - 2033 (USD Billion)
  • 6.5. Capsules
    • 6.5.1. Capsules Market, 2021 - 2033 (USD Billion)
  • 6.6. Oral Liquids
    • 6.6.1. Oral Liquids Market, 2021 - 2033 (USD Billion)
  • 6.7. Others
    • 6.7.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 7. Oral Analgesics Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2025 & 2033
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.5. Retail Pharmacies
    • 7.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.6. Online Pharmacies
    • 7.6.1. Online Pharmacies Market, 2021 - 2033 (USD Billion)

Chapter 8. Oral Analgesics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America Oral Analgesics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Billion)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Framework
      • 8.4.2.5. U.S. Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Framework
      • 8.4.3.5. Canada Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Framework
      • 8.4.4.5. Mexico Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5. Europe
    • 8.5.1. Europe Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Framework
      • 8.5.2.5. UK Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Framework
      • 8.5.3.5. Germany Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Framework
      • 8.5.4.5. France Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Framework
      • 8.5.5.5. Italy Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Framework
      • 8.5.6.5. Spain Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement Framework
      • 8.5.7.5. Denmark Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Target Disease Prevalence
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement Framework
      • 8.5.8.5. Sweden Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Target Disease Prevalence
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement Framework
      • 8.5.9.5. Norway Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Framework
      • 8.6.2.5. Japan Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Framework
      • 8.6.3.5. China Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Framework
      • 8.6.4.5. India Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Framework
      • 8.6.5.5. Australia Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement Framework
      • 8.6.6.5. South Korea Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Target Disease Prevalence
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement Framework
      • 8.6.7.5. Thailand Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Latin America Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Framework
      • 8.7.2.5. Brazil Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Framework
      • 8.7.3.5. Argentina Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Target Disease Prevalence
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement Framework
      • 8.8.2.5. South Africa Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Target Disease Prevalence
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement Framework
      • 8.8.3.5. Saudi Arabia Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Target Disease Prevalence
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement Framework
      • 8.8.4.5. UAE Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Target Disease Prevalence
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement Framework
      • 8.8.5.5. Kuwait Oral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Haleon plc
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Kenvue Inc.
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Bayer AG
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Reckitt Benckiser Group plc
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Teva Pharmaceutical Industries Ltd.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Viatris Inc.
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Sanofi
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Pfizer Inc.
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Sun Pharmaceutical Industries Ltd.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Cipla Limited
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives
Product Code: GVR-4-68041-065-9

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global oral analgesics market, by region, 2021 - 2033 (USD Billion)
  • Table 4 Global oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 5 Global oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 6 Global oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 7 Global oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 8 North America oral analgesics market, by country, 2021 - 2033 (USD Billion)
  • Table 9 North America oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 10 North America oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 11 North America oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 12 North America oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 13 U.S. oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 14 U.S. oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 15 U.S. oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 16 U.S. oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 17 Canada oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 18 Canada oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 19 Canada oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 20 Canada oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 21 Mexico oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 22 Mexico oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 23 Mexico oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 24 Mexico oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 25 Europe oral analgesics market, by country, 2021 - 2033 (USD Billion)
  • Table 26 Europe oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 27 Europe oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 28 Europe oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 29 Europe oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 30 UK oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 31 UK oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 32 UK oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 33 UK oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 34 Germany oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 35 Germany oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 36 Germany oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 37 Germany oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 38 France oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 39 France oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 40 France oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 41 France oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 42 Italy oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 43 Italy oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 44 Italy oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 45 Italy oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 46 Spain oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 47 Spain oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 48 Spain oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 49 Spain oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 50 Norway oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 51 Norway oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 52 Norway oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 53 Norway oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 54 Denmark oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 55 Denmark oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 56 Denmark oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 57 Denmark oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 58 Sweden oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 59 Sweden oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 60 Sweden oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 61 Sweden oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 62 Asia Pacific oral analgesics market, by country, 2021 - 2033 (USD Billion)
  • Table 63 Asia Pacific oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 64 Asia Pacific oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 65 Asia Pacific oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 66 Asia Pacific oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 67 Japan oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 68 Japan oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 69 Japan oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 70 Japan oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 71 China oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 72 China oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 73 China oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 74 China oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 75 India oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 76 India oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 77 India oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 78 India oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 79 Australia oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 80 Australia oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 81 Australia oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 82 Australia oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 83 South Korea oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 84 South Korea oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 85 South Korea oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 86 South Korea oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 87 Thailand oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 88 Thailand oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 89 Thailand oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 90 Thailand oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 91 Latin America oral analgesics market, by country, 2021 - 2033 (USD Billion)
  • Table 92 Latin America oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 93 Latin America oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 94 Latin America oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 95 Latin America oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 96 Brazil oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 97 Brazil oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 98 Brazil oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 99 Brazil oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 100 Argentina oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 101 Argentina oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 102 Argentina oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 103 Argentina oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 104 Middle East & Africa oral analgesics market, by country, 2021 - 2033 (USD Billion)
  • Table 105 Middle East & Africa oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 106 Middle East & Africa oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 107 Middle East & Africa oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 108 Middle East & Africa oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 109 South Africa oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 110 South Africa oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 111 South Africa oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 112 South Africa oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 113 Saudi Arabia oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 114 Saudi Arabia oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 115 Saudi Arabia oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 116 Saudi Arabia oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 117 UAE oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 118 UAE oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 119 UAE oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 120 UAE oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 121 Kuwait oral analgesics market, by drug class, 2021 - 2033 (USD Billion)
  • Table 122 Kuwait oral analgesics market, by prescription status, 2021 - 2033 (USD Billion)
  • Table 123 Kuwait oral analgesics market, by formulation, 2021 - 2033 (USD Billion)
  • Table 124 Kuwait oral analgesics market, by distribution channel, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Oral analgesics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Oral analgesics market dynamics
  • Fig. 11 Oral analgesics market: Porter's five forces analysis
  • Fig. 12 Oral analgesics market: PESTLE analysis
  • Fig. 13 Drug Class market, 2021 - 2033 (USD Billion)
  • Fig. 14 Non-opioid analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 15 Opioid analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 16 Combination analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 17 Prescription status market, 2021 - 2033 (USD Billion)
  • Fig. 18 OTC market, 2021 - 2033 (USD Billion)
  • Fig. 19 Prescription market, 2021 - 2033 (USD Billion)
  • Fig. 20 Formulation market, 2021 - 2033 (USD Billion)
  • Fig. 21 Tablets / Caplets market, 2021 - 2033 (USD Billion)
  • Fig. 22 Capsules market, 2021 - 2033 (USD Billion)
  • Fig. 23 Oral Liquids market, 2021 - 2033 (USD Billion)
  • Fig. 24 Others market, 2021 - 2033 (USD Billion)
  • Fig. 25 Distribution channel market, 2021 - 2033 (USD Billion)
  • Fig. 26 Hospital pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 27 Retail pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 28 Online pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 29 Oral analgesics market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 North America oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 32 U.S. country dynamics
  • Fig. 33 U.S. oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 34 Canada country dynamics
  • Fig. 35 Canada oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 36 Mexico country dynamics
  • Fig. 37 Mexico oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 38 Europe oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 39 UK country dynamics
  • Fig. 40 UK oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 41 Germany country dynamics
  • Fig. 42 Germany oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 43 France country dynamics
  • Fig. 44 France oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 45 Italy country dynamics
  • Fig. 46 Italy oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 47 Spain country dynamics
  • Fig. 48 Spain oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 49 Norway country dynamics
  • Fig. 50 Norway oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 51 Sweden country dynamics
  • Fig. 52 Sweden oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 53 Denmark country dynamics
  • Fig. 54 Denmark oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 55 Asia Pacific oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 56 Japan country dynamics
  • Fig. 57 Japan oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 58 China country dynamics
  • Fig. 59 China oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 60 India country dynamics
  • Fig. 61 India oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 62 Australia country dynamics
  • Fig. 63 Australia oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 64 South Korea country dynamics
  • Fig. 65 South Korea oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 66 Thailand country dynamics
  • Fig. 67 Thailand oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 68 Latin America oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 69 Brazil country dynamics
  • Fig. 70 Brazil oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 71 Argentina country dynamics
  • Fig. 72 Argentina oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 73 MEA oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 74 South Africa country dynamics
  • Fig. 75 South Africa oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 76 Saudi Arabia country dynamics
  • Fig. 77 Saudi Arabia oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 78 UAE country dynamics
  • Fig. 79 UAE oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 80 Kuwait country dynamics
  • Fig. 81 Kuwait oral analgesics market, 2021 - 2033 (USD Billion)
  • Fig. 82 Company categorization
  • Fig. 83 Company market position analysis
  • Fig. 84 Strategic framework
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!